#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia Alzheimer's type Muscular dystrophy Small for dates baby Cystic fibrosis lung Epilepsy with myoclonic-atonic seizures Pyoderma gangrenosum Retinal dystrophy Insulinoma Monogenic diabetes Epstein-Barr virus infection Mucous membrane pemphigoid Bile acid synthesis disorder Idiopathic inflammatory myopathy Adenocarcinoma gastric Endometrial cancer recurrent More trials…

    Learn about Rare Diseases

    Pulmonary fibrosis – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS Hereditary angioedema Antithrombin III deficiency – Diagnostics Haemophilia A without inhibitors – Treatment Glycogen storage disease type I – Basic Information Pelizaeus-Merzbacher disease – Life with Disease Pituitary-dependent Cushing’s syndrome – Diagnostics Mastocytosis – Basic Information Methylmalonic acidaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dosulepin Hydrochloride EGANELISIB Golexanolone Baxdrostat Rosuvastatin Clotrimazole Magnesium Chloride ALLERGEN EXTRACTS Desoximetasone XENON (133XE) Eliglustat Tartrate Alkaline Phosphatase, Bovine Prednisolone Acetate DESMOPRESSIN ACETATE Octocog Alfa Carboplatin Norfloxacin Sibeprenlimab T89 Fluocinolone Acetonide More therapies…

    Learn about Your Condition

    Bronchopulmonary dysplasia Hepatitis B Neck pain Oedema peripheral Upper limb fracture Lymphoedema Vitiligo Myelofibrosis Irritable bowel syndrome Tendon injury Pyrexia Castleman's disease Autism spectrum disorder Pseudomyxoma peritonei Neurogenic bladder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Cannabidiol compared to placebo to treat alcohol dependence in adults seeking treatment to achieve abstinence

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Alcohol abuse
    Investigated Drugs:
    • CANNABINOL
    Spain

  • Study comparing low-dose versus standard-dose epinephrine for better brain recovery in patients with out-of-hospital cardiac arrest

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Epinephrine Bitartrate
    France

  • Study of Telitacicept compared to placebo in adults with moderate to severe systemic lupus erythematosus

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Telitacicept
    Bulgaria Czechia France Germany Hungary Poland +1

  • Evaluation of BIO-101 versus placebo for treating severe sarcopenia in elderly patients with reduced mobility

    Not yet recruiting

    3 1
    Investigated Drugs:
    • 20-HYDROXYECDYSONE
    Belgium

  • Study of Disitamab Vedotin alone or with Pembrolizumab in patients with locally advanced or metastatic urothelial cancer that expresses HER2

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Disitamab Vedotin
    Belgium France Italy Spain

  • Safety and early effectiveness study of VG801 subretinal injection in patients with ABCA4 mutation-associated retinal dystrophy

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • VG801-1
    • VG801-2
    Germany
Previous Page
1 … 784 785 786 787 788 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!